Literature DB >> 15908393

Infection of newborn piglets with Bordetella pertussis: a new model for pertussis.

S Elahi1, R Brownlie, J Korzeniowski, R Buchanan, B O'Connor, M S Peppler, S A Halperin, S F Lee, L A Babiuk, V Gerdts.   

Abstract

Bordetella pertussis is the causative agent of pertussis or whooping cough. This bacterium is a human pathogen that under experimental conditions also infects selected rodents and primates. Here, we show for the first time that newborn piglets can be infected with B. pertussis when it is delivered intrapulmonarily. Infected piglets displayed fever and respiratory symptoms, such as nasal discharge, nonparoxysmal coughing, and breathing difficulties. Eventually, all infected animals developed severe bronchopneumonia, which in some cases was combined with a fibrinous pleuritits. Immunohistochemical staining revealed the presence of large numbers of B. pertussis cells within airways, adhering to the epithelial lining or phagocytosed by macrophages and neutrophils. Viable bacteria were reisolated from bronchoalveolar lavages and lung lesions for more than 10 days postinfection. The systemic presence of pertussis toxin was shown by hypoglycemia, lymphocytosis, and induction of a clustered pattern of CHO cells by serum and bronchoalveolar lavage samples. Thus, a large-animal model for pertussis was developed, which should complement existing rodent models for identifying the immune responses relevant to the design of new vaccines. In particular, this model should help researchers analyze the roles of both maternal and mucosal immunity in disease protection against pertussis and should ultimately assist in the design of new vaccines for early life protection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15908393      PMCID: PMC1111856          DOI: 10.1128/IAI.73.6.3636-3645.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Signalling and cellular specificity of airway nitric oxide production in pertussis.

Authors:  T A Flak; W E Goldman
Journal:  Cell Microbiol       Date:  1999-07       Impact factor: 3.715

Review 2.  Immunity to Bordetella pertussis.

Authors:  K H Mills
Journal:  Microbes Infect       Date:  2001-07       Impact factor: 2.700

Review 3.  Ethical issues for vaccines and immunization.

Authors:  Jeffrey B Ulmer; Margaret A Liu
Journal:  Nat Rev Immunol       Date:  2002-04       Impact factor: 53.106

Review 4.  Pertussis of adults and infants.

Authors:  C H Wirsing von König; S Halperin; M Riffelmann; N Guiso
Journal:  Lancet Infect Dis       Date:  2002-12       Impact factor: 25.071

5.  The structure of the nonreducing terminal groups in the O-specific polysaccharides from two strains of Bordetella bronchiseptica.

Authors:  E Vinogradov; M S Peppler; M B Perry
Journal:  Eur J Biochem       Date:  2000-12

Review 6.  Vaccination strategies for mucosal immune responses.

Authors:  P L Ogra; H Faden; R C Welliver
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 7.  The pig as a model of developmental immunology.

Authors:  H J Rothkötter; E Sowa; R Pabst
Journal:  Hum Exp Toxicol       Date:  2002 Sep-Oct       Impact factor: 2.903

8.  [Pertussis in young infants].

Authors:  A L Vegelin; A J van Vught; T F Wolfs; J L Kimpen; S P Geelen
Journal:  Ned Tijdschr Geneeskd       Date:  1998-12-05

Review 9.  Maternal immunization.

Authors:  W P Glezen; M Alpers
Journal:  Clin Infect Dis       Date:  1999-02       Impact factor: 9.079

10.  Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production.

Authors:  M Leef; K L Elkins; J Barbic; R D Shahin
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

View more
  26 in total

1.  Maternal immunity provides protection against pertussis in newborn piglets.

Authors:  Shokrollah Elahi; Rachelle M Buchanan; Lorne A Babiuk; Volker Gerdts
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  PBMC transcriptomic responses to primary and secondary vaccination differ due to divergent lean growth and antibody titers in a pig model.

Authors:  Marcel Adler; Eduard Murani; Siriluck Ponsuksili; Klaus Wimmers
Journal:  Physiol Genomics       Date:  2015-07-14       Impact factor: 3.107

Review 3.  Pertussis leukocytosis: mechanisms, clinical relevance and treatment.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2016-09-07       Impact factor: 3.166

Review 4.  Bordetella pertussis pathogenesis: current and future challenges.

Authors:  Jeffrey A Melvin; Erich V Scheller; Jeff F Miller; Peggy A Cotter
Journal:  Nat Rev Microbiol       Date:  2014-03-10       Impact factor: 60.633

5.  Protective Role of Passively Transferred Maternal Cytokines against Bordetella pertussis Infection in Newborn Piglets.

Authors:  Shokrollah Elahi; David R Thompson; Jill Van Kessel; Lorne A Babiuk; Volker Gerdts
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

6.  Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.

Authors:  David Vickers; Allen G Ross; Raúl C Mainar-Jaime; Cordell Neudorf; Syed Shah
Journal:  CMAJ       Date:  2006-11-07       Impact factor: 8.262

7.  Immunoproteomic analysis of human serological antibody responses to vaccination with whole-cell pertussis vaccine (WCV).

Authors:  Yong-Zhang Zhu; Cheng-Song Cai; Wei Zhang; Hong-Xiong Guo; Jin-Ping Zhang; Ya-Yong Ji; Guang-Yuan Ma; Jia-Lin Wu; Qing-Tian Li; Cheng-Ping Lu; Xiao-Kui Guo
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

8.  The host defense peptide beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets.

Authors:  Shokrollah Elahi; Rachelle M Buchanan; Sam Attah-Poku; Hugh G G Townsend; Lorne A Babiuk; Volker Gerdts
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

Review 9.  Advances in swine biomedical model genomics.

Authors:  Joan K Lunney
Journal:  Int J Biol Sci       Date:  2007-02-10       Impact factor: 6.580

10.  Low dose antigen exposure for a finite period in newborn rats prevents induction of mucosal tolerance.

Authors:  Rachelle M Buchanan; Sherry Tetland; Heather L Wilson
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.